Retractable Technologies, Inc. (RVP)
USD 0.59
(-8.8%)
USD 0.59
(-8.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 80.38 Million USD | -9.81% |
| 2022 | 89.12 Million USD | -16.81% |
| 2021 | 107.13 Million USD | 94.47% |
| 2020 | 55.09 Million USD | 418.0% |
| 2019 | 10.63 Million USD | -4.86% |
| 2018 | 11.17 Million USD | 1.79% |
| 2017 | 10.98 Million USD | 2.91% |
| 2016 | 10.67 Million USD | -7.32% |
| 2015 | 11.51 Million USD | -37.85% |
| 2014 | 18.52 Million USD | -8.28% |
| 2013 | 20.19 Million USD | 69.68% |
| 2012 | 11.9 Million USD | 17.73% |
| 2011 | 10.11 Million USD | -29.25% |
| 2010 | 14.29 Million USD | -20.7% |
| 2009 | 18.02 Million USD | 10.33% |
| 2008 | 16.33 Million USD | 29.95% |
| 2007 | 12.56 Million USD | 13.39% |
| 2006 | 11.08 Million USD | 5.36% |
| 2005 | 10.52 Million USD | -18.0% |
| 2004 | 12.82 Million USD | 51.02% |
| 2003 | 8.49 Million USD | -20.02% |
| 2002 | 10.62 Million USD | -42.2% |
| 2001 | 18.37 Million USD | 40.09% |
| 2000 | 13.11 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 75.3 Million USD | -1.32% |
| 2024 Q1 | 76.31 Million USD | -5.06% |
| 2023 FY | 80.38 Million USD | -9.81% |
| 2023 Q3 | 82.09 Million USD | -1.36% |
| 2023 Q2 | 83.22 Million USD | -3.44% |
| 2023 Q1 | 86.18 Million USD | -3.3% |
| 2023 Q4 | 80.38 Million USD | -2.08% |
| 2022 FY | 89.12 Million USD | -16.81% |
| 2022 Q1 | 102.17 Million USD | -4.63% |
| 2022 Q4 | 89.12 Million USD | -2.7% |
| 2022 Q2 | 91.78 Million USD | -10.17% |
| 2022 Q3 | 91.59 Million USD | -0.2% |
| 2021 Q4 | 107.13 Million USD | 8.88% |
| 2021 Q1 | 70.59 Million USD | 28.14% |
| 2021 Q2 | 101.05 Million USD | 43.16% |
| 2021 FY | 107.13 Million USD | 94.47% |
| 2021 Q3 | 98.39 Million USD | -2.63% |
| 2020 Q1 | 9.53 Million USD | -10.38% |
| 2020 FY | 55.09 Million USD | 418.0% |
| 2020 Q2 | 14.03 Million USD | 47.24% |
| 2020 Q3 | 28.03 Million USD | 99.74% |
| 2020 Q4 | 55.09 Million USD | 96.52% |
| 2019 Q1 | 10.14 Million USD | -9.27% |
| 2019 Q2 | 10.49 Million USD | 3.5% |
| 2019 Q3 | 11.29 Million USD | 7.63% |
| 2019 Q4 | 10.63 Million USD | -5.86% |
| 2019 FY | 10.63 Million USD | -4.86% |
| 2018 Q1 | 10.26 Million USD | -6.5% |
| 2018 FY | 11.17 Million USD | 1.79% |
| 2018 Q2 | 11.16 Million USD | 8.69% |
| 2018 Q3 | 11.25 Million USD | 0.86% |
| 2018 Q4 | 11.17 Million USD | -0.69% |
| 2017 Q3 | 12.3 Million USD | 6.42% |
| 2017 FY | 10.98 Million USD | 2.91% |
| 2017 Q2 | 11.56 Million USD | 7.35% |
| 2017 Q1 | 10.76 Million USD | 0.92% |
| 2017 Q4 | 10.98 Million USD | -10.74% |
| 2016 FY | 10.67 Million USD | -7.32% |
| 2016 Q4 | 10.67 Million USD | 1.82% |
| 2016 Q3 | 10.47 Million USD | -5.02% |
| 2016 Q2 | 11.03 Million USD | 8.04% |
| 2016 Q1 | 10.21 Million USD | -11.29% |
| 2015 Q1 | 18.38 Million USD | -0.76% |
| 2015 Q2 | 10.28 Million USD | -44.03% |
| 2015 Q3 | 11.29 Million USD | 9.73% |
| 2015 Q4 | 11.51 Million USD | 1.97% |
| 2015 FY | 11.51 Million USD | -37.85% |
| 2014 Q1 | 18.07 Million USD | -10.52% |
| 2014 Q4 | 18.52 Million USD | -5.81% |
| 2014 FY | 18.52 Million USD | -8.28% |
| 2014 Q3 | 19.66 Million USD | 4.1% |
| 2014 Q2 | 18.89 Million USD | 4.53% |
| 2013 Q1 | 9.97 Million USD | -16.22% |
| 2013 Q3 | 20.02 Million USD | 88.96% |
| 2013 Q4 | 20.19 Million USD | 0.85% |
| 2013 FY | 20.19 Million USD | 69.68% |
| 2013 Q2 | 10.59 Million USD | 6.27% |
| 2012 Q3 | 9.87 Million USD | -2.15% |
| 2012 Q4 | 11.9 Million USD | 20.54% |
| 2012 FY | 11.9 Million USD | 17.73% |
| 2012 Q2 | 10.09 Million USD | 0.03% |
| 2012 Q1 | 10.08 Million USD | -0.21% |
| 2011 FY | 10.11 Million USD | -29.25% |
| 2011 Q1 | 11.66 Million USD | -18.39% |
| 2011 Q2 | 11.27 Million USD | -3.29% |
| 2011 Q3 | 10.49 Million USD | -6.93% |
| 2011 Q4 | 10.11 Million USD | -3.68% |
| 2010 FY | 14.29 Million USD | -20.7% |
| 2010 Q1 | 17.18 Million USD | -4.64% |
| 2010 Q4 | 14.29 Million USD | 32.68% |
| 2010 Q2 | 15.08 Million USD | -12.19% |
| 2010 Q3 | 10.77 Million USD | -28.62% |
| 2009 Q3 | 15.59 Million USD | -5.03% |
| 2009 FY | 18.02 Million USD | 10.33% |
| 2009 Q4 | 18.02 Million USD | 15.52% |
| 2009 Q2 | 16.42 Million USD | -8.47% |
| 2009 Q1 | 17.94 Million USD | 9.87% |
| 2008 Q1 | 11.83 Million USD | -5.83% |
| 2008 Q4 | 16.33 Million USD | 23.24% |
| 2008 Q3 | 13.25 Million USD | 29.06% |
| 2008 FY | 16.33 Million USD | 29.95% |
| 2008 Q2 | 10.26 Million USD | -13.24% |
| 2007 Q1 | 13.99 Million USD | 26.22% |
| 2007 Q2 | 12.37 Million USD | -11.53% |
| 2007 FY | 12.56 Million USD | 13.39% |
| 2007 Q3 | 11.9 Million USD | -3.8% |
| 2007 Q4 | 12.56 Million USD | 5.56% |
| 2006 FY | 11.08 Million USD | 5.36% |
| 2006 Q4 | 11.08 Million USD | -4.53% |
| 2006 Q3 | 11.61 Million USD | 12.59% |
| 2006 Q2 | 10.31 Million USD | -0.4% |
| 2006 Q1 | 10.35 Million USD | -1.59% |
| 2005 Q4 | 10.52 Million USD | -17.36% |
| 2005 Q2 | 11.96 Million USD | -8.18% |
| 2005 Q3 | 12.72 Million USD | 6.39% |
| 2005 Q1 | 13.03 Million USD | 1.57% |
| 2005 FY | 10.52 Million USD | -18.0% |
| 2004 Q2 | 8.99 Million USD | 4.31% |
| 2004 Q3 | 20.74 Million USD | 130.63% |
| 2004 Q1 | 8.62 Million USD | 1.48% |
| 2004 FY | 12.82 Million USD | 51.02% |
| 2004 Q4 | 12.82 Million USD | -38.14% |
| 2003 FY | 8.49 Million USD | -20.02% |
| 2003 Q4 | 8.49 Million USD | 1.16% |
| 2003 Q1 | 11 Million USD | 3.63% |
| 2003 Q2 | 8.84 Million USD | -19.64% |
| 2003 Q3 | 8.39 Million USD | -5.06% |
| 2002 Q4 | 10.62 Million USD | -17.9% |
| 2002 Q3 | 12.93 Million USD | -1.88% |
| 2002 Q2 | 13.18 Million USD | -25.47% |
| 2002 Q1 | 17.69 Million USD | -3.74% |
| 2002 FY | 10.62 Million USD | -42.2% |
| 2001 Q3 | 16.08 Million USD | 5.6% |
| 2001 FY | 18.37 Million USD | 40.09% |
| 2001 Q2 | 15.23 Million USD | 10.96% |
| 2001 Q1 | 13.72 Million USD | 4.63% |
| 2001 Q4 | 18.37 Million USD | 14.26% |
| 2000 Q4 | 13.11 Million USD | 45.57% |
| 2000 Q3 | 9.01 Million USD | 0.0% |
| 2000 FY | 13.11 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| InfuSystem Holdings, Inc. | 57.58 Million USD | -39.598% |
| Milestone Scientific Inc. | 3.35 Million USD | -2293.11% |
| Stereotaxis, Inc. | 19.98 Million USD | -302.144% |